Skip to main content
SES-imagotag logo

SES-imagotag — Investor Relations & Filings

Ticker · SESL ISIN · FR0010282822 LEI · 969500U51BYOMEW9M549 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 696 across all filing types
Latest filing 2025-04-30 Share Issue/Capital Cha…
Country FR France
Listing PA SESL

About SES-imagotag

https://www.ses-imagotag.com/

SES-imagotag is a global provider of digital solutions for physical retail, specializing in Electronic Shelf Labels (ESLs) and pricing automation. The company develops a comprehensive Retail IoT platform, VUSION, which connects store shelves to the cloud. This ecosystem integrates smart digital labels, wireless communication infrastructure, sensors, and cameras to create intelligent and connected stores. The core technology enables retailers to automate price and promotion updates in real-time, ensuring accuracy and operational efficiency. Beyond pricing, the platform offers solutions for real-time inventory monitoring, on-shelf availability optimization, and data-driven analytics to improve store performance. It also supports in-store digital media, allowing retailers and brands to engage with shoppers at the shelf.

Recent filings

Filing Released Lang Actions
VusionGroup : Augmentation du flottant de VusionGroup dans le cadre d'une cession par voie de placement privé par BOE
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated April 30, 2025, detailing a significant change in shareholding structure: BOE is selling a portion of its stake via a private placement, which increases the free float, and VusionGroup is repurchasing a small portion of shares. It also mentions a resulting change in the Board of Directors (resignation of a BOE representative and the intent to appoint an independent director). This transaction involves capital structure changes, share dealings by a major shareholder, and governance updates. Since the core event is a major shareholder transaction leading to a change in capital structure and board composition, it strongly relates to Capital/Financing Update (CAP) or potentially Director's Dealing (DIRS) or Governance Information (CGR). However, the primary focus is the large block trade and the resulting capital structure shift (increase in free float, share repurchase). The most fitting category for significant changes in share ownership structure and related capital actions is 'Capital/Financing Update' (CAP). It is not a formal regulatory filing like a 10-K or IR, nor is it a simple announcement of a report (RPA/RNS).
2025-04-30 French
VusionGroup: Increase of VusionGroup's free float in the context of a private placement by BOE
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated April 30, 2025, announcing a significant change in shareholding structure involving BOE selling shares via a private placement, which reduces its stake and increases the free float. It also mentions the company buying back shares and an expected change in the Board of Directors composition. This content directly relates to capital structure changes, share transactions, and corporate governance updates. Since it is a press release announcing these specific corporate actions (share sale, buyback, board change), it fits best under Capital/Financing Update (CAP) due to the primary focus on share transactions and capital structure changes, or potentially Board/Management Information (MANG) due to the director change, but the share transaction is the catalyst. Given the detailed description of the share sale, buyback, and resulting free float change, 'CAP' is the most encompassing category for this type of market-moving announcement regarding equity structure. It is not a formal regulatory filing like a 10-K or IR, nor is it a general regulatory announcement (RNS) as it is highly specific.
2025-04-30 English
VusionGroup - Chiffre d'affaires du 1er trimestre 2025 : Forte croissance au premier trimestre. Confirmation des perspectives annuelles.
Earnings Release Classification · 100% confidence The document is a press release titled "VusionGroup – Chiffre d'affaires du 1er trimestre 2025: Forte croissance au premier trimestre Confirmation des perspectives annuelles". It details key financial metrics (revenue, order intake) for the first quarter (T1 2025) and reiterates annual guidance. This structure—reporting on a specific, shorter fiscal period (quarterly) with key highlights and management commentary, but not being the full, comprehensive report itself (like a 10-Q or 10-K)—is characteristic of an Earnings Release (ER). It is a summary announcement of results, not the full Interim Report (IR) or Annual Report (10-K). The document also mentions a conference call and future reporting dates, confirming its nature as an initial results announcement. Q1 2025
2025-04-23 French
VusionGroup - Q1 2025 Sales: Strong growth in the first quarter. Full-year guidance confirmed.
Earnings Release Classification · 100% confidence The document is titled "VusionGroup – Q1 2025 Sales: Strong growth in the first quarter. Full-year guidance confirmed." It presents key financial figures (€215 million IFRS sales, €233 million adjusted sales) and order intake for the first quarter (Q1 2025) compared to the prior year (Q1 2024). It also confirms the full-year outlook. This structure—presenting period-specific financial highlights immediately following the period's end (Press Release April 23, 2025, covering Q1 2025)—is characteristic of an Earnings Release (ER). It is not a comprehensive, audited report (10-K) or a detailed interim report (IR), as it focuses on highlights and guidance confirmation, often preceding the full quarterly report. The presence of a conference call announcement further supports this classification. Q1 2025
2025-04-23 English
La chaîne de pharmacies Dr. Max s'associe à VusionGroup pour digitaliser ses magasins en Europe
Regulatory Filings Classification · 100% confidence The document is explicitly titled 'Communiqué de presse' (Press Release) and dated February 15, 2025. It announces a new strategic partnership between Dr. Max and VusionGroup regarding the digitalization of stores. This type of announcement, detailing a significant business development or partnership, is typically classified as a general regulatory announcement or press release that doesn't fit the specific financial report categories (like 10-K, ER, IR). Since it is a formal announcement of a business event rather than a detailed financial report, the most appropriate general category is Regulatory Filings (RNS), as it serves as a broad announcement mechanism for material, non-standardized news.
2025-04-15 French
Leading Pharmacy Chain Dr. Max Partners with VusionGroup for Advanced Store Digitalization across Europe
Regulatory Filings Classification · 100% confidence The document is a press release dated April 15, 2025, announcing a partnership and technology roll-out between Dr. Max and VusionGroup. It details a business agreement, strategic goals, and implementation timelines. This type of announcement, which is not a formal regulatory filing (like 10-K, IR, or ER) but rather a significant business update intended for the market and investors, best fits the 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially 'Capital/Financing Update' (CAP) if the partnership involved significant capital terms, but RNS is the most appropriate general category for press releases not covered elsewhere. Since it is a detailed announcement of a business development rather than a short notice of a report publication, it is not RPA. It is not about management changes (MANG), insider trading (DIRS), or dividends (DIV). Therefore, RNS is the best fit.
2025-04-15 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.